Lygos Acquires Librede to Accelerate Cannabinoid Production for Consumer, Nutraceutical and Pharmaceutical Products

Cannabinoids

Home » Health and medicine » Cannabinoids

European synthetic biology company Octarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives

With investors including Oskare Capital and Canopy Growth Cooperation founder Bruce Linton January 10, 2020 05:00 AM Eastern Standard Time COPENHAGEN, Denmark–(BUSINESS WIRE)–Today, Octarine Bio IVS...

Amyris Announces Successful Shipment of First Fermentation Derived Cannabinoid to LAVVAN and Provides Business Updates

Teewinot Announces Availability of Cannabinol for Commercial Cannabinoid Market

Proprietary manufacturing process, CannSynthesis®, produces cannabinol oil at >98% purity with no detectable THC First company to manufacture cannabinol using chemical synthesis at commercial scale TAMPA, Fla., Oct...

Lygos Acquires Librede to Accelerate Cannabinoid Production for Consumer, Nutraceutical and Pharmaceutical Products

Cannabinoids

European synthetic biology company Octarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives

Amyris Announces Successful Shipment of First Fermentation Derived Cannabinoid to LAVVAN and Provides Business Updates

Teewinot Announces Availability of Cannabinol for Commercial Cannabinoid Market

Forget The Grow Room And The Plant: Companies Can Now Brew Cannabis Like Beer

Renew Biopharma Announces Landmark Patent in Cannabinoid Biosynthesis; CEO to Speak Today at SynBioBeta

Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies

Cannabinoid Fermentation Report

Intrexon Corporation and Surterra Wellness Partner in $100M Deal to Advance Commercial Scale Fermentation-based Cannabinoid Production

Triple green threat: Why cannabinoids are synbio’s next big market

International Cannabis, Biotii and Y Combinator Backed Biotech Innovator to Build Bioworks Foundry

ICC Makes Strategic Investment in Disruptive Biosynthesis Research — CFN Media

Genetically modified tequila bacterium produces cannabinoids from sugar: Farmako applies for a worldwide patent